Tuesday, January 1, 2008

FDA Warns Consumers Not to Use Home-Use Diagnostic Kits Marketed by Globus Media

The Food and Drug Organization (FDA) is word of advice consumers not to use unapproved home-use diagnostic test kits that have been marketed nationwide via the Internet by Globus Media, Montreal, Canada. In fact, no home-use test kits intended for diagnosing HIV, syphilis and dengue anticipation are approved for sale in the U.S. The use of these products could upshot in false results (though there is no confirmed grounds of false positives) that could lead to significant adverse condition consequences. The illegal kits are labeled as:


-- Rapid HIV Test Kit
-- Rapid Syphilis Test Kit
-- One Step Cassette Way Cocaine Test
-- One Step Cassette Perceptiveness marijuana (THC) Test
-- One Step Cassette Manner Amphetamine Test
-- Rapid Dengue Expectancy Test
-- One Step Midstream Stylus HCG Urine (Home)


-- Pregnancy Test FDA learned of the question from two consumer complaints. FDA has not approved or evaluated the operation of any of Globus Media's products. As a solution, consumers cannot know with any state of sure thing that test results are correct. For object lesson, a being experiment film for HIV (human immunodeficiency representation, or the AIDS virus) using one of these tests may not be infected with HIV, or, worse, someone infected with HIV may test film and not seek medical direction or scatter the micro-organism to others. The tests were sold through web sites and distributed throughout the U.S., usually by overnight transfer services. These have been made available for sale on several web sites, including www.htkit.com and www.hstkits.com. The kits usually are contained in a public press cover with instructions region the promotion. The covering, instructions and promotion may not accurately identify the shaper, meat packer or distributer. The name of the kit appears on the instructions. Consumers who have these products should not use them. Anyone who has used one of these test kits should be retested using valid test methods. The FDA has issued an implication signaling which alerts FDA business personnel department to the applier commercialism of these devices, provides content as to their penalization and subject matter of incoming into the U.S., and also advises U.S.

No comments: